Lipella Pharmaceuticals Inc (LIPO)
0.66
-0.01
(-1.49%)
USD |
NASDAQ |
Jun 14, 16:00
0.66
0.00 (0.00%)
After-Hours: 19:19
Lipella Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.0655 |
| December 31, 2022 | 0.0588 |
| Date | Value |
|---|---|
| September 30, 2022 | -1.194 |
| June 30, 2022 | 0.213 |
| March 31, 2022 | 0.0815 |
| December 31, 2021 | 0.0527 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-1.194
Minimum
Sep 2022
0.213
Maximum
Jun 2022
-0.0803
Average
0.0527
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.5332 |
| IGC Pharma Inc | 0.0152 |
| NovaBay Pharmaceuticals Inc | 6.294 |
| Protalix BioTherapeutics Inc | 0.6856 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.137M |
| Total Liabilities (Quarterly) | 0.5759M |
| Shareholders Equity (Quarterly) | 2.561M |